Viewing Study NCT01839604

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:51 PM
Ignite Modification Date: 2026-02-22 @ 6:46 PM
Study NCT ID: NCT01839604
Status: COMPLETED
Last Update Posted: 2017-03-06
First Post: 2013-03-21
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: A Phase I/Ib Study of AZD9150 (ISIS-STAT3Rx) in Patients With Advanced/Metastatic Hepatocellular Carcinoma
Sponsor: AstraZeneca
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Adult Hepatocellular Carcinoma View
None Hepatocellular Carcinoma Metastatic View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Child-Pugh A to B7, View
None Advanced/Metastatic Hepatocellular Carcinoma, View
None AZD9150, View
None Antisense Oligonucleotide Inhibitor of STAT3 View